Evoke Pharma Inc (EVOK) Annual Income Statement (USD)
EVOK Quarterly Financials (USD)
Frequently Asked Questions About Evoke Pharma Inc (EVOK) Stock
Evoke Pharma Inc's (EVOK) last reported annual revenue was USD 5.18 Million.
Evoke Pharma Inc's (EVOK) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Evoke Pharma Inc's(EVOK) is not profitable as of its last reported annual financials.
The net profit margin for Evoke Pharma Inc's(EVOK) from its laster reported year is -150.41%
The return on equity (ROE) for Evoke Pharma Inc's(EVOK) from its last reported annual financials is : -1035.44%
The return on assets (ROA) for Evoke Pharma Inc's(EVOK) from its last reported annual financials is : -49.09%
The return on invested capital (ROIC) for Evoke Pharma Inc's(EVOK) from its last reported annual financials is : 0.00%
The Debt to Equity ratio for Evoke Pharma Inc's(EVOK) from its last reported annual financials is : -193.83%
The dividend yield for Evoke Pharma Inc's(EVOK) from its laster reported year is 0.00%
Evoke Pharma Inc's(EVOK) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for EVOK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
